Kaleido Biosciences, Inc. (KLDO): Price and Financial Metrics
KLDO Price/Volume Stats
| Current price | $0.00 | 52-week high | $0.03 |
| Prev. close | $0.00 | 52-week low | $0.00 |
| Day low | $0.00 | Volume | 935 |
| Day high | $0.00 | Avg. volume | 4,361 |
| 50-day MA | $0.00 | Dividend yield | N/A |
| 200-day MA | $0.00 | Market Cap | 4.26K |
KLDO Stock Price Chart Interactive Chart >
Kaleido Biosciences, Inc. (KLDO) Company Bio
Kaleido Biosciences, Inc. is a healthcare company, which focuses on leveraging the potential of the microbiome organ to treat disease and improve human health. The company was founded by Geoffrey von Maltzahn and Noubar B. Afeyan in 2015 and is headquartered in Lexington, MA.
Latest KLDO News From Around the Web
Below are the latest news stories about Kaleido Biosciences Inc that investors may wish to consider to help them evaluate KLDO as an investment opportunity.
Global Blood's (GBT) Q4 Earnings Miss Mark, Revenues Rise Y/YGlobal Blood (GBT) reports wider-than-expected loss in the fourth quarter of 2021 while revenues are slightly above estimates. |
Kaleido Biosciences, Inc. (KLDO) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 ReleaseKaleido Biosciences, Inc. (KLDO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. |
Novavax (NVAX) to Report Q4 Earnings: What's in the Cards?On Novavax's (NVAX) fourth-quarter earnings call, investor focus is likely to be on the initial sales numbers of the company's COVID-19 vaccine. |
Is a Beat Likely for Perrigo (PRGO) This Earnings Season?Perrigo's (PRGO) new products as well as products added through acquisitions are expected to have aided the company's top line in the soon-to-be-reported quarter. |
Blueprint Medicines (BPMC) Q4 Loss Widens, Revenues Top MarkBlueprint Medicines (BPMC) misses on earnings while revenue beat estimates for the fourth quarter of 2021. Stock down. |
KLDO Price Returns
| 1-mo | 0.00% |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | 0.00% |
| 3-year | 0.00% |
| 5-year | 0.00% |
| YTD | N/A |
| 2023 | 0.00% |
| 2022 | -99.98% |
| 2021 | -73.74% |
| 2020 | 81.27% |
| 2019 | N/A |
Loading social stream, please wait...